Peptinov

Peptinov

Private
ParisHealthcare & Life Scienceshttps://peptinov.fr/

Last Round

Grant

Apr 23, 2024

Total Funding Raised

$5.05M

Company Overview

Peptinov is a biotechnology company that develops immunotherapies for the treatment of chronic inflammatory diseases and cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

therapeutic vaccineactive immunotherapyanti-IL-6 therapychronic inflammatory diseaseIL-6 inhibitorpeptide immunotherapyknee osteoarthritispeptide vaccinedisease-modifying therapyclinical-stage biotechDMOADdrug discovery platformpharma licensingcancer immunotherapyendometriosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Peptinov Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Peptinov Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantApr 23, 2024
Venture - Series UnknownMay 23, 2023
VC RoundMar 1, 2023
VC RoundNov 15, 2021
SeedSep 4, 2019

Key People

Founding team and executive leadership

René Azoulai

CEO

Executive Team

Herve Do

CFO Head Of Business Development

Executive Team

SAS PEPTINOV

Chief Financial Officer

Executive Team

Peptinov Investors

Notable investors and investment history

InvestorRounds
Happy CapitalSeed, VC Round
Les Business Angels des Grandes ÉcolesAngel, VC Round
Groupe IRCEMVC Round
BpifranceGrant
IRCEM PrévoyanceVenture - Series Unknown, Seed, VC Round
Business Angels des Grandes EcolesVenture - Series Unknown

Peptinov Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Peptinov Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Peptinov's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range17
Year Founded2010
Last FundingApr 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.